ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

YourUpdateTV Speaks with Cardiologist and Family Heart Foundation Ambassador About a Hidden Genetic Risk to Heart Health

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Heart disease remains the leading cause of death in America, yet many remain unaware of the genetic risk factors that could increase their chances of heart attack or stroke. High Lipoprotein(a), or Lp(a), is the most common genetic condition contributing to early cardiovascular disease, but less than 5% of Americans are screened for it. Recently, Cardiologist Dr. Keith Ferdinand and Family Heart Foundation Ambassador, Susan Riley, participated in a nationwide media tour to discuss this genetic risk factor, the impacts, and resources that can help.

What is High Lipoprotein(a)?
High Lipoprotein(a) is a genetic condition that increases the risk of early heart attacks and strokes. It is one of the most common genetic risk factors for cardiovascular disease, yet it remains largely underdiagnosed. A simple blood test can help identify the condition, but only a small percentage of the population is screened for it.

Everyone is encouraged to be screened for high Lp(a), especially individuals with a family history of heart disease or stroke, as well as those from higher-risk groups such as Black or South Asian communities. Understanding Lp(a) levels can lead to earlier interventions and better management of cardiovascular risk.

Susan Riley’s Story
High Lp(a) runs in Susan’s family. Her husband was diagnosed with high Lp(a) over 12 years ago after multiple stents were placed due to cardiovascular issues. Following his diagnosis, two of their three children also found that they had high Lp(a). Sadly, their 23-year-old daughter Catherine passed away from a heart attack in her sleep, a loss that highlighted the dangers of high Lp(a).

Riley eventually decided to get her own Lp(a) levels tested, which also came back high. Now, she focuses on staying informed about the condition and remains committed to spreading awareness so that others don’t suffer the same fate.

Steps for Managing High Lp(a)
While specific treatments for high Lp(a) are still in development, there are actions people can take now to manage their risk. This includes controlling other cardiovascular risk factors, such as lowering LDL cholesterol (“bad” cholesterol) and managing high blood pressure, which can help mitigate the impact of high Lp(a).

Getting Screened
If you or someone in your family has a history of heart disease or stroke, consider getting screened for Lp(a). Early detection is key to reducing the risk of heart attack or stroke. A free at-home screening kit is available from the Family Heart Foundation at CholesterolConnect.org.

For additional information, resources, and Care Navigation support, visit FamilyHeart.org.

About Susan Riley
Susan Riley’s journey with elevated Lipoprotein(a), or Lp(a), began after a series of family health challenges. In 2010, her husband required two stents at age 43, and later, her active and health-conscious daughter, Catherine, passed away unexpectedly. The loss of Catherine, who had a passion for marine conservation, inspired Susan to take action. After debating for years, she finally had her own Lp(a) tested in 2022, discovering her levels were high. Since then, Susan, along with her other daughter Courtney, have become Family Heart Ambassadors. Through their advocacy, they aim to raise awareness about the genetic risks of high Lp(a) and encourage others to get screened. Now, three generations of the Riley family are working to honor Catherine’s legacy and educate others about the importance of managing Lp(a) levels for heart health.

About Dr. Keith Ferdinand
Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA, began his medical career with a bachelor’s degree in biology from the University of New Orleans, followed by a medical degree from Howard University College of Medicine. He completed his internship at the US Public Health Hospital in New Orleans, and his internal medicine residency and cardiology fellowship at Louisiana State University, Medical Center, with an additional cardiology fellowship at Howard University Hospital. Dr. Ferdinand has held clinical, research, and teaching positions at institutions such as Xavier University, LSU, Baylor College of Medicine, and Emory University, before returning to New Orleans as a Professor of Clinical Medicine at Tulane University Heart and Vascular Institute. He has been actively involved in national public health organizations, including serving as the former Chair and Chief Science Officer of the Association of Black Cardiologists and as the immediate-past Chair of the National Forum for Heart Disease and Stroke Prevention. With a focus on cardiac risk factors, particularly in minority communities, Dr. Ferdinand has published more than 100 manuscripts and maintains a strong media presence. His dedication to patient care is reflected in his nonprofit work and community service, and he was inducted into the Association of University Cardiologists in 2015.

* YourUpdateTV is a property of D S Simon Media. The video included and release was part of a media tour that was produced by D S Simon Media on behalf of the Family Heart Foundation.

Dante Muccigrosso
Director of Media Integration & Client Reporting
E: dantem@dssimon.com
C: 973.524.0104

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b4c5ebfe-20fb-4bef-b18f-39bd4e80a701


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.